These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24216511)

  • 21. The triterpenoid CDDO-Me delays murine acute graft-versus-host disease with the preservation of graft-versus-tumor effects after allogeneic bone marrow transplantation.
    Li M; Sun K; Redelman D; Welniak LA; Murphy WJ
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):739-50. PubMed ID: 20338256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR; Majewski D; Hanson G
    Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delayed infusion of immunocompetent donor cells after bone marrow transplantation breaks graft-host tolerance allows for persistent antileukemic reactivity without severe graft-versus-host disease.
    Johnson BD; Truitt RL
    Blood; 1995 Jun; 85(11):3302-12. PubMed ID: 7756664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secondary lymphoid organs contribute to, but are not required for the induction of graft-versus-host responses following allogeneic bone marrow transplantation: a shifting paradigm for T cell allo-activation.
    Silva IA; Olkiewicz K; Askew D; Fisher JM; Chaudhary MN; Vannella KM; Deurloo DT; Choi SW; Pierce EM; Clouthier SG; Liu C; Cooke KR
    Biol Blood Marrow Transplant; 2010 May; 16(5):598-611. PubMed ID: 20117226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unique patterns of surface receptors, cytokine secretion, and immune functions distinguish T cells in the bone marrow from those in the periphery: impact on allogeneic bone marrow transplantation.
    Zeng D; Hoffmann P; Lan F; Huie P; Higgins J; Strober S
    Blood; 2002 Feb; 99(4):1449-57. PubMed ID: 11830499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-throughput sequencing of RNAs isolated by cross-linking immunoprecipitation (HITS-CLIP) reveals Argonaute-associated microRNAs and targets in Schistosoma japonicum.
    Zhao J; Luo R; Xu X; Zou Y; Zhang Q; Pan W
    Parasit Vectors; 2015 Nov; 8():589. PubMed ID: 26577460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondrial Deacetylase SIRT3 Plays an Important Role in Donor T Cell Responses after Experimental Allogeneic Hematopoietic Transplantation.
    Toubai T; Tamaki H; Peltier DC; Rossi C; Oravecz-Wilson K; Liu C; Zajac C; Wu J; Sun Y; Fujiwara H; Henig I; Kim S; Lombard DB; Reddy P
    J Immunol; 2018 Dec; 201(11):3443-3455. PubMed ID: 30389773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA regulation of molecular networks mapped by global microRNA, mRNA, and protein expression in activated T lymphocytes.
    Grigoryev YA; Kurian SM; Hart T; Nakorchevsky AA; Chen C; Campbell D; Head SR; Yates JR; Salomon DR
    J Immunol; 2011 Sep; 187(5):2233-43. PubMed ID: 21788445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Completely allogeneic spleen cells induced cytolytic neonatal tolerance to alloantigens, but failed to establish allo-helper interactions with host T cells.
    Ramos A; González M; López-Hoyos M; Carrió R; Merino J
    Immunology; 1996 Nov; 89(3):413-8. PubMed ID: 8958055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation.
    Truitt RL; Johnson BD; Hanke C; Talib S; Hearst JE
    J Immunol; 1999 Nov; 163(9):5145-56. PubMed ID: 10528221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T cell activation induces proteasomal degradation of Argonaute and rapid remodeling of the microRNA repertoire.
    Bronevetsky Y; Villarino AV; Eisley CJ; Barbeau R; Barczak AJ; Heinz GA; Kremmer E; Heissmeyer V; McManus MT; Erle DJ; Rao A; Ansel KM
    J Exp Med; 2013 Feb; 210(2):417-32. PubMed ID: 23382546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Manipulation of graft-versus-host disease for a graft-versus-leukemia effect after allogeneic bone marrow transplantation in AKR mice with spontaneous leukemia/lymphoma.
    Truitt RL; Shih CC; LeFever AV
    Transplantation; 1986 Mar; 41(3):301-10. PubMed ID: 3513389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Host reactive donor T cells are associated with lung injury after experimental allogeneic bone marrow transplantation.
    Cooke KR; Krenger W; Hill G; Martin TR; Kobzik L; Brewer J; Simmons R; Crawford JM; van den Brink MR; Ferrara JL
    Blood; 1998 Oct; 92(7):2571-80. PubMed ID: 9746799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of stem cell transcriptional programs normally expressed in embryonic and neural stem cells in alloreactive CD8+ T cells mediating graft-versus-host disease.
    Kato K; Cui S; Kuick R; Mineishi S; Hexner E; Ferrara JL; Emerson SG; Zhang Y
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):751-71. PubMed ID: 20116439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease.
    Alpdogan O; Schmaltz C; Muriglan SJ; Kappel BJ; Perales MA; Rotolo JA; Halm JA; Rich BE; van den Brink MR
    Blood; 2001 Oct; 98(7):2256-65. PubMed ID: 11568014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PKCtheta is required for alloreactivity and GVHD but not for immune responses toward leukemia and infection in mice.
    Valenzuela JO; Iclozan C; Hossain MS; Prlic M; Hopewell E; Bronk CC; Wang J; Celis E; Engelman RW; Blazar BR; Bevan MJ; Waller EK; Yu XZ; Beg AA
    J Clin Invest; 2009 Dec; 119(12):3774-86. PubMed ID: 19907075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome-wide identification of translationally inhibited and degraded miR-155 targets using RNA-interacting protein-IP.
    Meier J; Hovestadt V; Zapatka M; Pscherer A; Lichter P; Seiffert M
    RNA Biol; 2013 Jun; 10(6):1018-29. PubMed ID: 23673373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Murine acute graft-versus-host disease can be prevented by depletion of alloreactive T lymphocytes using activation-induced cell death.
    Hartwig UF; Robbers M; Wickenhauser C; Huber C
    Blood; 2002 Apr; 99(8):3041-9. PubMed ID: 11929798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allogeneic versus semiallogeneic F1 bone marrow transplantation into sublethally irradiated MHC-disparate hosts. Effects on mixed lymphoid chimerism, skin graft tolerance, host survival, and alloreactivity.
    Pierce GE
    Transplantation; 1990 Jan; 49(1):138-44. PubMed ID: 2137269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delta-like ligand 4 identifies a previously uncharacterized population of inflammatory dendritic cells that plays important roles in eliciting allogeneic T cell responses in mice.
    Mochizuki K; Xie F; He S; Tong Q; Liu Y; Mochizuki I; Guo Y; Kato K; Yagita H; Mineishi S; Zhang Y
    J Immunol; 2013 Apr; 190(7):3772-82. PubMed ID: 23440416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.